Literature DB >> 17018304

Diagnostic value of multidetector row CT in rectal cancer staging: comparison of multiplanar and axial images with histopathology.

R Sinha1, R Verma, A Rajesh, C J Richards.   

Abstract

AIM: Although magnetic resonance (MR) imaging is widely used for rectal cancer staging, many centres in the UK perform computed tomography (CT) for staging rectal cancer at present. Furthermore in a small proportion of cases contraindications to MR imaging may lead to staging using CT. The purpose of this study was to evaluate the accuracy of current generation multidetector row CT (MDCT) in local staging of rectal cancer. In particular the accuracy of multiplanar (MPR) versus axial images in the staging of rectal cancer was assessed.
MATERIAL AND METHODS: Sixty-nine consecutive patients were identified who had undergone staging of rectal cancer on CT. The imaging data were reviewed as axial images and then as MPR images (coronal and sagittal) perpendicular and parallel to the tumour axis. CT staging on axial and MPR images was then compared to histopathological staging.
RESULTS: MPR images detected more T4 and T3 stage tumours than axial images alone. The overall accuracy of T-staging on MPR images was 87.1% versus 73.0% for axial images alone. The overall accuracy of N staging on MPR versus axial images was 84.8% versus 70.7%. There was a statistically significant difference in the staging of T3 tumours between MPR and axial images (p<0.001).
CONCLUSION: Multidetector row CT has high accuracy for local staging of rectal cancer. Addition of MPR images to standard axial images provides higher accuracy rates for T and N staging of rectal cancer than axial images alone.

Entities:  

Mesh:

Year:  2006        PMID: 17018304     DOI: 10.1016/j.crad.2006.03.019

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  17 in total

Review 1.  Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.

Authors:  Siva P Raman; Yifei Chen; Elliot K Fishman
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 2.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Computerized Tomography Criteria as a Tool for Simplifying the Assessment of Locally Advanced Rectal Cancer.

Authors:  Oren Gal; Dan Feldman; Amir Mari; Fadi Abu Baker; Dan Hebron; Yael Kopelman
Journal:  J Gastrointest Cancer       Date:  2020-03

4.  Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion.

Authors:  Davide Ippolito; Silvia Girolama Drago; Cammillo Talei Franzesi; Davide Fior; Sandro Sironi
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

5.  The value of true axial imaging for CT staging of colonic cancer.

Authors:  Ewan M Anderson; Margaret Betts; Andrew Slater
Journal:  Eur Radiol       Date:  2010-11-26       Impact factor: 5.315

6.  CT multiplanar reconstructions (MPR) for shrapnel injury trajectory.

Authors:  Olga R Brook; Ayelet Eran; Ahuva Engel
Journal:  Emerg Radiol       Date:  2011-10-14

7.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

Review 8.  MRI in local staging of rectal cancer: an update.

Authors:  Umit Tapan; Mustafa Ozbayrak; Servet Tatlı
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

Review 9.  [Preoperative staging of rectal cancer].

Authors:  A-O Schäfer; T Baumann; G Pache; T Wiech; M Langer
Journal:  Radiologe       Date:  2007-07       Impact factor: 0.635

10.  Overstaging: A Challenge in Rectal Cancer Treatment.

Authors:  Jan Scheele; Stefan Andreas Schmidt; Sandra Tenzer; Doris Henne-Bruns; Marko Kornmann
Journal:  Visc Med       Date:  2018-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.